Skip to main content
Premium Trial:

Request an Annual Quote

Eagle Names HB Technologies its Distributor in Central Europe

NEW YORK (GenomeWeb News) – UK Bioinformatics company Eagle appointed German software firm HB Technologies as its distributor in Central Europe under a deal announced today.

The products and services deal covers Germany, Austria, Switzerland, and Luxembourg and allows Eagle to "significantly" expand its reach in the German-speaking market. HB Technologies will "source new projects and opportunities" for Eagle, which will continue to carry out delivery and implementation work, the firms said.

Financial and other terms of the deal were not disclosed.

"Eagle views overseas representation as key to continued expansion of its already substantial international customer base," Eagle Chief Business Officer Richard Holland said in a statement. "With existing customers in the UK, USA, France, Belgium, Denmark, the Netherlands, Switzerland, Germany, Malaysia, and Singapore, Eagle is no stranger to the business of working across time zones and through language barriers."

Eagle is based in Cambridge, UK, and specializes in bioinformatics, and computational and systems biology. During the summer, it announced plans to raise $1.6 million in preparation of a launch of its cloud-based life sciences data analysis product and an expansion of its staff.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.